EDGAR Filing Documents for 0001193125-19-226901

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-19-226901

Filing Date

2019-08-22

Accepted

2019-08-22 16:31:24

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3/A	d764306ds3a.htm	S-3/A	338618
2	GRAPHIC	g764306g10v95.jpg	GRAPHIC	64255
	Complete submission text file	0001193125-19-226901.txt		428388

Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139

Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300

X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)